| 13492 |
Androgen Receptor (Phospho-Ser210,213) Monoclonal Antibody (Clone 156C135.2)
|
|
- |
|
|
|
2009-08-27
|
2.031233885819
|
androgen-receptor-phospho-ser210-213-monoclonal-antibody-clone-156c135-2
|
AR
|
WB western blots immunoblotting IHC immunohistochemistry paraffin receptors signaling pathway blotting |
2.031233885819
|
| 10009410 |
ATF2 (Phospho-Ser490,498) Polyclonal Antibody
|
|
- |
|
|
|
2006-11-28
|
1.522790055248
|
atf2-phospho-ser490-498-polyclonal-antibody
|
Activating Transcription Factor 2
|
wb western blotting blots ihc immunohistochemistry antibodies activating transcriptional factors CRE-BP1 AP-1 DNA response elements ATF/CREB leucine zipper proteins regulating regulation genes cytokines cells cycles controls apoptosis death cellular stress inflammatory UV irradiation activity phosphorylation serines brains substrates neuronal neurons growth differentiation human depression phospho-specific immunoblotting |
1.522790055248
|
| 600130 |
ATF2 (Phospho-Thr69,71) Transcription Factor Assay Kit
|
|
- |
|
|
|
2009-11-11
|
22.910218483173
|
atf2-phospho-thr69-71-transcription-factor-assay-kit
|
Activating Transcription Factor 2
|
kits measuring measurement assays tf activating DNA-binding proteins bZIP octameric cyclic AMP-responsive elements CRE promoter regions genes mediates mediation DNA damage controls phosphorylation/activation inflammatory cytokines UV irradiation alkylating compounds cells cellular stressors pThr69,71 Thr69 Thr71 JNK/p38 homodimers heterodimers ATF/CREB Fos Fra2 c-Jun CREB ATF1 cycles control drug resistance apoptosis tumorigenesis insulin biosynthesis non-radioactive detection detecting nuclear extracts ELISA enzyme-linked immunosorbent assay double-stranded dsDNA colorimetric 69 71 phosphorylated |
22.910218483173
|
| 13502 |
Bnc 1 Polyclonal Antibody
|
|
- |
|
|
|
2009-09-09
|
0E-12
|
bnc-1-polyclonal-antibody
|
|
antibodies transcription factor WB western blots immunoblotting blotting zing finger protein phosphorylation Ser537 Ser541 Bnc1 Bnc-1 TFs |
0E-12
|
| 11140 |
CAY10657
New
|
|
494772-86-0 |
≥98%
|
|
|
2012-03-05
|
15.173864708261
|
cay10657
|
|
NF-κB, transcription factors inflammation arthritis chemotherapy IKK IKK2 inhibitors IKB thiophenecarboximide inhibits inhibitions IKK-2 IKK 2 NFkB NF kB Rel NF-kB/Rel pro-inflammatory genes cytokines chemokines interferons MHC proteins growth factors cells adhesion cancers |
15.173864708261
|
| 10004985 |
Caylin-1
|
|
- |
≥98%
|
|
|
2005-09-09
|
16.462107340173
|
caylin-1
|
|
caylin1 mdm-2 cancer Nutlin-3 analogs p53 inhibits inhibitors inhibition interaction Mdm2 negative regulators activity chlorine substituents phenyl rings growth HCT-116 cells promotes |
16.462107340173
|
| 10005002 |
Caylin-2
|
|
- |
>98%
|
|
|
2004-07-12
|
11.607382596685
|
caylin-2
|
|
apoptosis cancer p53 inhibits inhibitors induces apoptotic re-activation reactivation antioncogenic tumors xenografts HCT-116 caylin2 |
11.607382596685
|
| 10009524 |
ChREBP DBD (human recombinant)
|
|
- |
>85% by SDS-PAGE
|
|
|
2007-04-12
|
1.953729281768
|
chrebp-dbd-human-recombinant
|
GenBank Accession No. BC012925; Carbohydrate Response Element-binding Protein DNA Binding Domain; WS-bHLH; Williams-Beuren Syndrome Chromosome Region 14
|
EMSA electrophoretic mobility shift assays transcription factors proteins diabetes obesity insulin HLH MLXIPL MIO WBSCR14 endocrinology CAS number # 352845-69-3 |
1.953729281768
|
| 10009753 |
ChREBP DBD Western Ready Control
|
|
- |
|
|
|
2007-05-03
|
1.953729281768
|
chrebp-dbd-western-ready-control
|
Carbohydrate Response Element-binding Protein DNA Binding Domain; WS-bHLH; Williams-Beuren Syndrome Chromosome Region 14
|
WB western blot western blotting Thr666 PP2A carbohydrate response element CRE L-type pyruvate kinase L-PK glucose Ser196 endocrinology |
1.953729281768
|
| 13505 |
HIF-2α Polyclonal Antibody
|
|
- |
|
|
|
2009-07-31
|
28.071616022099
|
hif-2-polyclonal-antibody
|
Hypoxia Inducible Factor-2α
|
antibodies HIF2 HIFs ARNT hpoxias factors WB blots western immunoblotting blotting |
28.071616022099
|
| 10009818 |
NF-κB (p50) (human recombinant)
|
|
- |
>75%
|
|
|
2007-06-20
|
24.009060773481
|
nf-b-p50-human-recombinant
|
NF-κB1; Nuclear Factor-κB (p50)
|
transcription factors proteins homodimers heterodimers p50/p105 p52/p100 RelA c-Rel genes cytokines chemokines immunoreceptors cell adhesion molecules DNA expression phosphorylation p ubiquitination subsequent degradation I.kappa.B.alpha. diseases therapeutics human nfkb nf-kb nf.-kappa.b nf.kappa.b |
24.009060773481
|
| 10010184 |
NF-κB (p50) Western Ready Control
|
|
- |
Whole cell lysate
|
|
|
2007-07-19
|
23.556764009471
|
nf-b-p50-western-ready-control
|
Nuclear Factor-κB (p50); NF-κB1
|
western blot WB transcription factors p50 p105 p52 p100 regulating cytokines chemokines immunoreceptors cell adhesion molecules mammals |
23.556764009471
|
| 13751 |
NF-κB (p65) NLS Polyclonal Antibody
|
|
- |
|
|
|
2010-02-11
|
20.545580110496
|
nf-b-p65-nls-polyclonal-antibody
|
Nuclear Factor-κB (p65) Nuclear Localization Signal
|
NFκB NF κB NF-.kappa.B NF.kappa.B NFkB NF-kB transcription factors N-terminal C-terminal terminals terminus signals tissues nuclear receptors western blots blotting immunoblotting WB immunocytochemistry ICC antibodies |
20.545580110496
|
| 10004806 |
p53 Monoclonal Antibody (Clone BP53-12)
|
|
- |
|
|
|
2004-06-17
|
3.627384898710
|
p53-monoclonal-antibody-clone-bp53-12
|
|
proteins WB western blots blotting antibodies antisera antiserum DNA anti-oncogenic apoptosis cancers p53 apoptotic antioncogenic flow cytometry immunocytochemistry ICC IHC immunohistochemistry transcription factors cellular stress damage hypoxia shock guardian of the genome special:month specialdiscount:15 specialstart:2008-01-01 specialend:2008-01-31 immunoblotting FC |
3.627384898710
|
| 10005291 |
p53 Product Pack
|
|
- |
|
|
|
2004-09-08
|
10.753913443830
|
p53-product-pack
|
|
DNA binding anti-oncogenic apoptosis cancer p53 re-activators reactivators induces apoptotic re-activation reactivation antioncogenic packs |
10.753913443830
|
| 10009088 |
PPARα LBD (human recombinant)
|
|
- |
≥90%
|
|
|
2006-09-13
|
56.225207182320
|
ppar-lbd-human-recombinant
|
Peroxisome Proliferator-activated Receptor α Ligand Binding Domain
|
peroxisomes proliferator-activated receptors PPARs proliferator activated PPARalpha PPAR.alpha. PPARa PPARα PPAR-α PPAR-alpha alpha a α .alpha. PPAR-.alpha. PPAR-a recombinant proteins nuclear family families ligand activated trascription factors heterodimerize retinoic acids genes expression differentiation hNUC1 FAAR PPARβ PPARδ PPARγ liver skeletal muscles brown fats hearts kidneys livers fatty acids FAAH atherosclerotic lesions NSAIDs prostaglandins PGs leukotrienes B4 LTs LTB LTB4 WY 14643 WY-14643 WY14643 hypolipidemic CoA acyl-CoA oxidase enol-CoA hydratase dehydrogenase cytochromes P450 4A amino acids 170-430 E.coli gels electrophoresis coomassie statining western blots immunoblotting WB blotting |
56.225207182320
|
| 61700 |
PPARγ FL (human recombinant from E. coli)
|
|
- |
>90% by SDS-PAGE
|
|
|
2007-01-10
|
27.604745242480
|
ppar-fl-human-recombinant-from-e-coli
|
Peroxisome Proliferator-activated Receptor γ Full Length (human recombinant)
|
peroxisomes proliferator-activated receptors PPARs proliferator activated PPARgamma PPAR.gamma. PPARg PPARγ PPAR-γ PPAR-gamma gamma g γ .gamma. PPAR-.gamma. PPAR-g human recombinant nuclear receptors ligands activated ligand-activated activates transcription factors heterodimerizes retinoic acids gene expression differentiation hormones subtypes PPARα PPARδ hNUC1 PPARβ pathology obese obesity diabetes atherosclerosis cancers adipose tissues expressed colon immune systems retina DNA binding domains binds DBD transcription factor assays 10006855 gel electrophoresis coomassie stains staining fluorescent displacement ANS rosiglitazone |
27.604745242480
|
| 10009987 |
PPARγ FL (human recombinant from Sf21 cells)
|
|
- |
≥80% by SDS-PAGE
|
|
|
2007-06-15
|
33.559779005524
|
ppar-fl-human-recombinant-from-sf21-cells
|
Peroxisome Proliferator-activated Receptor γ Full Length (human recombinant from Sf21 cells)
|
proteins binding enzymes PPAR.gamma. PPARgamma diseases obesity diabetes atherosclerosis cancers endocrinology |
33.559779005524
|
| 10007941 |
PPARγ LBD (human recombinant)
|
|
- |
≥90%
|
|
|
2006-03-16
|
20.752995702885
|
ppar-lbd-human-recombinant
|
Peroxisome Proliferator-activated Receptor γ Ligand Binding Domain
|
peroxisomes proliferator-activated receptors PPARs proliferator activated PPARgamma PPAR.gamma. PPARg PPARγ PPAR-γ PPAR-gamma gamma g γ .gamma. PPAR-.gamma. PPAR-g recombinant proteins atherosclerosis diabetes endocrinology genes regulations metabolic syndrome nuclear receptors obese obesity PPAR proteins biochemistry hexahistidine-tagged tagged hexahistidine HIS-tag HIS-tagged HIS N-terminal PPARalpha PPAR.alpha. PPARα PPAR-alpha PPAR-.alpha. PPAR-α PPAR-delta PPAR-.delta. PPAR-δ PPARdelta PPAR.delta. PPARδ hNUC1 FAAR pathology diseases cancers domains LBD ligand binds binding DNA DBD RXR acid-like acid like heterodimerization thiazolidinedione rosiglitazone piolitazone insulin type II E. coli coomassie stains staining western blots blotting immunoblotting WB fluorescent |
20.752995702885
|
| 10007451 |
PPARδ (human recombinant)
|
|
- |
≥95%
|
|
|
2005-07-29
|
13.889472068754
|
ppar-human-recombinant
|
NUC1; PPARβ; Peroxisome Proliferative Activated Receptor δ; Nuclear Hormone Receptor 1; FAAR
|
peroxisomes proliferator-activated receptors PPARs proliferator activated PPARdelta PPAR.delta. PPARd PPARδ PPAR-δ PPAR-delta delta .delta. δ PPAR-.delta. PPAR-d recombinant proteins human atherosclerosis cancers EMSA electrophoretic mobility shift assays endocrinology fluorescence metabolic syndrome nuclear obese obesity biochemistry transcription factors members retionic acids genes expression developments baculovirus Sf21 heterodimerize subtypes hNUC1 FAAR ubiquitously tissues mediator embryo implantation overexpression systems gels coomassie stains staining western blots WB immunoblotting 10006914 |
13.889472068754
|
| 10009568 |
PPARδ Western Ready Control
|
|
- |
|
|
|
2007-02-02
|
3.709790055248
|
ppar-western-ready-control
|
Peroxisome Proliferative Activated Receptor δ; Nuclear Hormone Receptor 1; FAAR; PPARβ; NUC1
|
peroxisomes proliferator-activated receptors PPARs proliferator activated PPARdelta PPAR.delta. PPARd PPARδ PPAR-δ PPAR-delta delta .delta. δ PPAR-.delta. PPAR-d genes families family Xenopus laevis PPARβ expressed tissues liver intestine kidney abdominal sipose skeletal muscles lipids metabolism mediator physiological functions cholesterol homeostasis embryo implantation cancers developments obese obesity |
3.709790055248
|
| 63520 |
PRIMA-1
|
|
5608-24-2 |
>95%
|
|
|
|
19.669569850039
|
prima-1
|
|
DNA binding anti-oncogenic apoptosis cancer p53 re-activator reactivator induces apoptotic re-activation reactivation antioncogenic cancers 2,2-bis(hydroxymethyl)-1-azabicyclo[2.2.2]octan-3-one |
19.669569850039
|
| 10008841 |
Propylpyrazole Triol
|
|
263717-53-9 |
≥98%
|
|
|
2007-01-25
|
89.196277624309
|
propylpyrazole-triol
|
PPT
|
17b-estrogen 17beta-estrogen 17.beta.-estrogen receptors ERalpha ER.alpha. ERbeta ER.beta. agonist ischemia DPN diarylpropinitrile in vivo infarct endocrinology |
89.196277624309
|
| 10009749 |
SREBP-2 Western Ready Control
|
|
- |
94 kDa (GST-tagged); 68 kDa (native)
|
|
|
2007-07-30
|
14.372972375690
|
srebp-2-western-ready-control
|
Sterol Regulatory Element-binding Transcription Factor 2; Sterol Regulatory Element-binding Protein 2; SREBPF2
|
WB western blot helix loop bHLH fatty acids genes cholesterol regulatory HMG-CoA tissues E. coli SREBP2 SREBPF-2 transcription factors SREBP 2 atherosclerosis |
14.372972375690
|